165 related articles for article (PubMed ID: 23845469)
21. The evaluation of MSX2 mRNA expression level in biliary brush cytological specimens.
Ito H; Satoh K; Hamada S; Hirota M; Kanno A; Ishida K; Unno J; Masamune A; Katayose Y; Unno M; Shimosegawa T
Anticancer Res; 2011 Mar; 31(3):1011-7. PubMed ID: 21498730
[TBL] [Abstract][Full Text] [Related]
22. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.
Barr Fritcher EG; Kipp BR; Halling KC; Clayton AC
Cytopathology; 2014 Oct; 25(5):288-301. PubMed ID: 25073411
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic tissue diagnosis of cholangiocarcinoma.
Harewood GC
Curr Opin Gastroenterol; 2008 Sep; 24(5):627-30. PubMed ID: 19122506
[TBL] [Abstract][Full Text] [Related]
24. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
[TBL] [Abstract][Full Text] [Related]
25. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Njei B; McCarty TR; Varadarajulu S; Navaneethan U
Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
[TBL] [Abstract][Full Text] [Related]
26. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
[TBL] [Abstract][Full Text] [Related]
27. ERCP tissue sampling.
Korc P; Sherman S
Gastrointest Endosc; 2016 Oct; 84(4):557-71. PubMed ID: 27156656
[No Abstract] [Full Text] [Related]
28. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
29. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
30. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding.
Kim DG; Park SY; You KR; Lee GB; Kim H; Moon WS; Chun YH; Park SH
Genes Chromosomes Cancer; 2001 Jan; 30(1):48-56. PubMed ID: 11107175
[TBL] [Abstract][Full Text] [Related]
32. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas.
DeHaan RD; Kipp BR; Smyrk TC; Abraham SC; Roberts LR; Halling KC
Hum Pathol; 2007 Mar; 38(3):491-9. PubMed ID: 17239935
[TBL] [Abstract][Full Text] [Related]
33. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
34. A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin.
Boldorini R; Paganotti A; Andorno S; Orlando S; Mercalli F; Orsello M; Ballarè M; Magnani C; Sartori M
J Clin Pathol; 2015 Apr; 68(4):283-7. PubMed ID: 25681513
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients.
Ainthachot S; Sa-Ngiamwibool P; Thanee M; Watcharadetwittaya S; Chamgramol Y; Pairojkul C; Deenonpoe R
Hum Pathol; 2022 Aug; 126():31-44. PubMed ID: 35577140
[TBL] [Abstract][Full Text] [Related]
36. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.
Uhm KO; Park YN; Lee JY; Yoon DS; Park SH
Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence in situ hybridization for the detection of malignant bile duct strictures: has FISH found a new pond?
Wamsteker EJ; Anderson MA
Am J Gastroenterol; 2004 Sep; 99(9):1682-3. PubMed ID: 15330901
[TBL] [Abstract][Full Text] [Related]
39. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
40. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma.
Hamada S; Satoh K; Hirota M; Kanno A; Ishida K; Umino J; Ito H; Kikuta K; Kume K; Masamune A; Katayose Y; Unno M; Shimosegawa T
Cancer Sci; 2011 Jan; 102(1):150-6. PubMed ID: 21029254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
